# SPFM, LLC – FDA Inspection, Feb 6, 2026

Source: https://www.keypedia.com/records/fda_inspections/spfm-llc/81d794ea-2b3d-4619-90e6-838488b180e9
Source feed: FDA_Inspections

> FDA inspection 1302210 of SPFM, LLC, February 06, 2026. 1 citation under 21 CFR part 1271. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302210
- Company Name: SPFM, LLC
- Inspection Date: 2026-02-06
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 912600 - 2015-02-04
- FDA Inspection 732289 - 2011-06-21

## Related Officers

- [Company Rep](https://www.keypedia.com/people/robert-m-tillman/091c720a-1240-468f-8b05-2b3f6f5a14bd)

Company: https://www.keypedia.com/companies/spfm-llc/6da18fe4-fb3f-480b-a68d-d6523529e717

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9